Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-16
2006-05-16
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S018000
Reexamination Certificate
active
07045527
ABSTRACT:
Compounds, compositions and methods are provided that are useful in the treatment or prevention of conditions or disorders associated with a neuropeptide receptor. The subject methods are particularly useful in the treatment and/or prevention of endocrine, metabolic, cardiovascular, neurologic, psychiatric, gastrointestinal, genitourinary and other disorders.
REFERENCES:
patent: 5219860 (1993-06-01), Chambers et al.
patent: 5324733 (1994-06-01), Billington et al.
patent: 5457207 (1995-10-01), Efange et al.
patent: 5554752 (1996-09-01), Efange et al.
patent: 5780437 (1998-07-01), Goulet et al.
patent: 6200957 (2001-03-01), Goulet et al.
patent: 6262066 (2001-07-01), Tulshian et al.
patent: 414289 (1994-02-01), None
patent: WO9614318 (1996-05-01), None
patent: WO9721704 (1997-06-01), None
patent: WO9846569 (1998-10-01), None
patent: WO9964002 (1999-12-01), None
patent: WO0006545 (2000-02-01), None
patent: WO0054772 (2000-09-01), None
patent: WO0107606 (2001-02-01), None
patent: WO0206245 (2002-01-01), None
An, et al., “Identification and Characterization of a melanin-concentrating hormone receptor”Proc. Natl. Acad. Sci.(2001) 98:7576-7581.
Bachner, et al., “Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1)”FEBS Lett.(1999) 457(3):522-524.
Barnes, et al. “Pharmacological Comparison of the Sigma Recognition Site Labeled by3Hhaloperidol in Human and Rat Cerebellum”, Naunyn-Schmiedeberg's Arch Pharmacol (1992), 345:197-202.
Bednarek, et al, “Short Segment of Human Melanin-Concentrating Hormone That is Sufficient for Full Activation of Human Melanin-Concentrating Hormone Receptors 1 and 2”, Biochemistry (2001) 40:9379-9386.
Bergeron, et al., “Biphasic Effects of Sigma Ligands on the Neuronal Response to N-Methyl-D-Aspartate”, Naunyn-Schmiedeberg's Arch Pharmacol (1995), 351:252-260.
Bergeron, et al., Effects of Low and High Doses of Selective Sigma Ligands: Further Evidence Suggesting Existence of Different Subtypes of Sigma Receptors3, Psychopharmacology (1997), 129:215-224.
Boutin, et al, “Melanin-Concentrating Hormone and its Receptors: State of the Art”, Can J. Physiol Pharmacol. (2002) 80:388-395.
Chambers, et al. “Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1”, Nature (1999) 400: 261-265.
Chambers, et al. “Spiropiperidines as High Affinity, Selective σ Ligands”,J. Med. Chem (1992) 35: 2033-2039.
Church, et al. “Blockade by Sigma Site Ligands of High-Voltage-Activated CA2+Channels in Rat and Mouse Cultured Hippocampal Pyramidal Neurones”, Britsih J. of Pharmacology (1995) 116: 2801-2810.
Couture, et al. “Some of the Effects of the Selective Sigma Ligand (+) Pentazocine Are Mediated Via a Naloxone-Sensitive Receptor” Synapse (2001) 39:323-331.
Efange, et al. “Spirovesamicols: Conformationally Restricted Analogs of 2-(4-Phenylpiperidine) Cyclohexanol (Vesamicol, AH5183) as Potential Modulators of Presynaptic Cholinergic Function” J. Med. Chem. (1994) 37: 2574-2582.
Efange, et al. “N-Hydroxyalkyl Derivatives of 3β-Phenyltropane and 1-Methylspirol {1H-Indoline 3,4′-Piperidine}: Vesamicol Analogues With Affinity for Monoamine Transporters”, J. Med. Chem. (1997) 40: 3905-3914.
Gonzalez, et al., “alpha-Melanocyte-stimulating hormone (alpha-MSH) and melanin-concentrating hormone (MCH) modify monoaminergic levels in the preoptic area of the rat”Peptides(1997) 18:387-392.
Hashigaki, et al. “Synthesis and Structure-Activity Relationship of Spiro [Isochroman-Piperidine] Analogs for Inhibition of Histamine Release. IV”, Chem Pharm. Bull. (1984) 32(9): 3561-3568.
Hawes, et al., “The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways”Endocrinology.(2000) 141: 4524-4532.
Hervieu, et al. “Similarities in cellular expression and functions of melanin-concentrating hormone and atrial natriuretic factor in the rat digestive tract”,Endocrinology(1996) 137: 561-571.
Hill, et al., “Molecular cloning and functional characterization of MCH2, a novel human MCH receptor”J. Biol Chem(2001) 276(23)20125-20129.
Jezova, et al., “Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier”Endocrinology.(1992) 130:1024-1029.
Mclamon, et al. “The Actions of L-687,384, a σ Receptor Ligand, on NMDA-Induced Currents in Cultured Rat Hippocampal Pyramidal Neurons” Neurosci Letter. (1994), 174(2): 181-184.
Miller, et al. “Alpha-MSH and MCH Are Functional Antagonists in a CNS Auditory Gating Paradigm”,Peptides(1993) 14: 431-440.
Mori, et al., “Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor”Biochem. Biophys. Res. Commun.(2001) 283:1013-1018.
Parkes, et al., “Contrasting actions of melanin-concentrating hormone and neuropeptide-E-I on posterior pituitary function”Ann N Y Acad Sci.(1993) 680:588-90.
Qu, et al., “A role for melanin-concentrating hormone in the central regulation of feeding behaviour”Naturet.(1996) 380:243-247.
Rodriguez, et al. “Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2”,Mol. Pharmacol.(2001) 60(4): 632-639.
Rossi, et al., “Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight”Endocrinology(1997) 138:351-355.
Sailer, et al., “Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R.”Proc. Natl. Acad. Sci..(2001)98: 7564-7569.
Saito, et al. “Molecular characterization of the melanin-concentrating-hormone receptor”,Nature(1999) 400: 265-269.
Saito, et al., “Melanin-concentrating hormone receptor: an orphan receptor fits the key”Trends Endocrinol. Metab.(2000) 11(8): 299-303.
Shimada, et al., “Mice Lacking melanin-concentrating hormone are Hypophagic and Lean”,Nature(1998) 396: 670-674.
Wang, et al. “Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, mch-r2”,J. Biol Chem.,(2001) 276(37):34664-34670.
Chen Xiaoqi
Dai Kang
Fan Pingchen
Fu Ying
Li Leping
Amgen Inc.
Desai Rita
Jones Day
LandOfFree
Piperidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3573123